HepTAC Virtual Learning Collaborative (VLC)
The VLC is a virtual learning community and training series designed to support viral hepatitis health department staff implement the viral hepatitis prevention and surveillance activities set forth in CDC’s Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments (CDC-RFA-PS21-2103) and is open to all state, territorial, and local health departments.
Download overview here.
Download FAQs here.
We are looking for speakers to share their viral hepatitis expertise during the Virtual Learning Collaborative Year 3. Please click here to indicate which dates and topics you are interested in presenting and discussing with other jurisdictions. Thank you!
VLC Year 3
The VLC Year 3 sessions are taking place from September 2023 through July 2024. The format for Y3 of the VLC will consist of two monthly sessions. During each session, the first half will be a presentation and the second half will be discussion-based. Sessions will range from 60-90 minutes depending on the topics and begin at 3:00 PM ET.
VLC Calendar, 2023-2024
|20-Sep-23||Workshop||Demystifying syndemic approaches in elimination planning for viral hepatitis programs|
|27-Sep-23||Presentation||Cross-jurisdictional approaches to syndemic planning and implementation|
|18-Oct-23||Presentation||Partnering with healthcare providers to advance viral hepatitis elimination and to support populations aging with viral hepatitis|
|1-Nov-23||Workshop||Updates to acute and chronic hepatitis B case definition|
|15-Nov-23||Workshop||Health systems assessment: Implementation and follow-up activities|
|7-Feb-24||Workshop||Developing a longitudinal database registry in NBS|
|21-Feb-24||Presentation||Developing an annual surveillance publication and identifying tools to increase public awareness/access (health equity)/understanding of hepatitis surveillance data|
|6-Mar-24||Presentation||Lessons Learned from HRSA SPNS: Leveraging a Data to Care (D2C) Approach to Cure Hepatitis C Virus (HCV) within the Ryan White HIV/AIDS Program (RWHAP)|
|20-Mar-24||Presentation||Understanding state immunizations programs and section 317 immunization programs to increase access to adult hepatitis vaccination services|
|3-Apr-24||Workshop||Viral hepatitis elimination plan implementation|
|17-Apr-24||Workshop||Implementing anti-racist and harm reduction practices into elimination planning and VH activities|
|1-May-24||Presentation||Improving provider awareness and capacity to increase viral hepatitis testing and treatment, Part 2|
Re-centering key populations: Viral hepatitis response to NASTAD’s Chair’s Challenge
|5-Jun-24||Workshop||Using social vulnerability index and other data sources to supplement viral hepatitis surveillance data to increase health equity|
|26-Jun-24||Workshop||Implementing lessons learned from the perinatal HBV case management program to inform perinatal HCV surveillance and case management|
|10-Jul-24||Presentation||Viral hepatitis prevention, testing, treatment and linkage to care services at state and local corrections|
|24-Jul-24||Presentation||FY25 Viral hepatitis policy update|
VLC Year 2
The VLC Year 2 sessions took place from September 2022 through July 2023, from 3:00 - 4:00 pm ET.
Session recordings and presentation slides can be found below.
VLC Calendar, 2022-2023
|21-Sep-22||Presentation||Implementing Hepatitis Services in High-Impact Settings|
|26-Oct-22||Presenation||Laboratory and Health Systems Assessment for Hepatitis Programs|
|16-Nov-22||Presentation||Engaging Non-Traditional Partners and People with Lived Experience in Elimination Planning and Implementation|
|30-Nov-22||Workshop||Engaging Non-Traditional Partners and People with Lived Experience in Elimination Planning and Implementation||N/A||N/A|
|8-Feb-23||Presentation||Using a health equity approach to improve data collection and use of demographic data (sex, gender identity, race, and ethnicity) and risk factors|
|22-Feb-23||Workshop||Using a health equity approach to improve data collection and use of demographic data (sex, gender identity, race, and ethnicity) and risk factors||N/A||N/A|
|8-Mar-23||Presentation||Working across the health department and with other state agencies to increase collaboration on viral hepatitis prevention and surveillance activities.|
|22-Mar-23||Workshop||Working across the health department and with other state agencies to increase collaboration on viral hepatitis prevention and surveillance activities.||N/A||N/A|
|5-Apr-23||Presentation||New York State and NYC Hepatitis C Telehealth Toolkit Overview|
|19-Apr-23||Presentation||Characteristics of hepatitis B mortality and considerations for health departments in analyzing cause of death data|
|26-Apr-23||Presentation||Hepatitis C: State of Medicaid Access 2023 Report Card Update|
|3-May-23||Presentation||Implementing negative/undetectable HBV DNA and HCV RNA lab reporting|
|17-May-23||Workshop||Implementing negative/undetectable HBV DNA and HCV RNA lab reporting||N/A||N/A|
|7-Jun-23||Workshop||Elimination planning next steps: Monitoring and Evaluation||N/A||N/A|
|21-Jun-23||Presentation||Corrections for Viral Hepatitis: 340B|
|5-Jul-23||Presentation||Trauma-Informed Approaches for Viral Hepatitis||N/A|
|26-Jul-23||Presentation||FY24 Hepatitis Policy Look-Ahead|
VLC Year 1
The VLC Year 1 sessions took place from October 2021 through July 2022 from 3:00 - 4:30 pm ET.
Session recordings and presentation slides can be found below.
VLC Calendar, 2021-2022
|8-Sep-21||Surveillance Guidance Overview|
|22-Sep-21||Developing an elimination plan: Core components and establishing achievable targets|
|13-Oct-21||Building or enhancing a coalition to eliminate viral hepatitis, Part I|
|27-Oct-21||Conducting case investigation activities in resource- and capacity-limited settings (DIS)|
|10-Nov-21||Outbreak 101, Part I (HAV)|
|15-Dec-21||Special VLC Session on Hepatitis C|
|12-Jan-22||Building or enhancing a coalition to eliminate viral hepatitis, Part II|
|26-Jan-22||Statutes and mandates for viral hepatitis condition and laboratory reporting|
|9-Feb-22||Outbreak 101, Part II (HBV & HCV)|
|23-Feb-22||Critical partnerships to improve viral hepatitis testing|
|9-Mar-22||Improving provider awareness and capacity to increase viral hepatitis testing and treatment|
|23-Mar-22||Establishing partnerships in settings (clinical, behavioral and laboratory) that conduct high volume of viral hepatitis testing to improve reporting and data quality|
|13-Apr-22||Attributes of an electronic surveillance system that can collect and store viral hepatitis lab reports, clinical data, and other case data|
|27-Apr-22||Improving capacity of PH labs and clinics to conduct all VH testing and report results electronically to HDs|
|11-May-22||Removing restrictions on access to hepatitis treatment|
|25-May-22||HCV RNA reflex testing: Updates and experience of commercial laboratories|
|8-Jun-22||Building longitudinal databases/registries and development of HCV CoCs|
|15-Jun-22||Establishing and conducting surveillance and case management for perinatal HCV among pregnant persons|
|13-Jul-22||Working in coalition to advance viral hepatitis testing: SSPs and MAT settings|
|27-Jul-22||Leveraging existing data sources for case matching|
On August 10 and 11, 2021, NASTAD, in collaboration with CDC, hosted the Viral Hepatitis Prevention and Surveillance Virtual Learning Collaborative Kickoff. This virtual event gathered close to 200 participants from health departments to provide core capacity training for viral hepatitis prevention and surveillance and featured sessions directed at building the core competencies of participants to facilitate effective implementation of activities under CDC's new viral hepatitis cooperative agreement Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments or PS21-2103.